Summit Therapeutics (SMMT) Times Interest Earned (2024)
Summit Therapeutics (SMMT) has disclosed Times Interest Earned for 1 consecutive years, with -$7290.4 as the latest value for Q4 2024.
- For the quarter ending Q4 2024, Times Interest Earned changed N/A year-over-year to -$7290.4, compared with a TTM value of -$26.02 through Dec 2024, changed N/A, and an annual FY2024 reading of -$26.02, up 29.75% over the prior year.
- Times Interest Earned was -$7290.4 for Q4 2024 at Summit Therapeutics, down from -$23.79 in the prior quarter.
- Across five years, Times Interest Earned topped out at -$13.58 in Q1 2024 and bottomed at -$7290.4 in Q4 2024.